- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Avelumab, immunotherapy, PD-L1 inhibitor, non-small cell lung cancer (NSCLC), urothelial cancer (UC)
Total 161754 results
-
Shanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruitingSafety Issues | Effect Increased
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer | Solid Tumors | Programmed Cell Death-1 (PD1, PD-1) | Programmed Cell Death 1 Ligand 1(PDL1, PD-L1) | Programmed Cell Death 1 Ligand 2 (PDL2, PD-L2)Japan
-
AstraZenecaActive, not recruitingCarcinoma, Non-Small-Cell LungPoland, Taiwan, India, Mexico, Russian Federation, Turkey, China, Korea, Republic of, Philippines, Hong Kong
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLung Diseases | Neoplasms by Site | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Respiratory Tract Disease | Neoplasm, BronchialChina
-
The Netherlands Cancer InstituteBristol-Myers SquibbTerminated
-
Tianjin Medical University Cancer Institute and...RecruitingEarly Stage Non-small Cell Lung CancerChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Checkpoint Therapeutics, Inc.Novotech (Australia) Pty LimitedRecruitingMelanoma | Renal Cell Carcinoma | Head and Neck Cancer | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Non Hodgkin Lymphoma | Endometrial Cancer | Carcinoma, Small Cell | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Malignant Mesothelioma, AdvancedAustralia, New Zealand, Thailand, Ukraine, Spain, Russian Federation, France, Poland, South Africa
-
Fudan UniversityRecruiting
-
The First People's Hospital of LianyungangRecruitingLung NeoplasmsChina
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruiting
-
Academic Thoracic Oncology Medical Investigators...AstraZenecaCompletedNon-Small Cell Lung Cancer NSCLCUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsUnited States, Korea, Republic of, Taiwan, France, United Kingdom, Belgium, Czechia, Germany, Poland
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
Xinqiao Hospital of ChongqingCompleted
-
Fondazione Ricerca TraslazionaleUnknownCarcinoma, Non-Small-Cell Lung
-
Hunan Province Tumor HospitalRecruitingNon-small Cell Lung CancerChina
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Stand Up To Cancer; CellSight Technologies, Inc.TerminatedNon-small Cell Lung Cancer (NSCLC)United States
-
MedImmune LLCAstraZenecaCompletedCarcinoma, Non-Small-Cell LungUnited States, Korea, Republic of, Japan
-
AmgenRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Australia, Netherlands, Taiwan, Korea, Republic of, United Kingdom, Spain, Austria, Japan, Switzerland, Sweden, France, China, Czechia, Italy, Portugal, Thailand, Hong Kong, Singapore, Bulgaria, Turkey, Mexico, Argentina and more
-
UNICANCERNational Cancer Institute, FranceRecruitingNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Metastatic | Non-Small Cell Carcinoma of Lung, TNM Stage 4France, Monaco
-
Kostas N.SyrigosCompleted
-
Intima Bioscience, Inc.Not yet recruitingCarcinoma, Non-Small-Cell Lung | Adenocarcinoma of Lung | Stage IV Non-small Cell Lung Cancer | Squamous Cell Lung Cancer | Metastatic Non Small Cell Lung Cancer | Large Cell Lung CancerUnited States
-
Shanghai Chest HospitalMerck Sharp & Dohme LLCRecruiting
-
University Hospital, AngersCompletedCancer | Sleep Apnea Syndromes, ObstructiveFrance
-
Tatarstan Cancer CenterUnknownHereditary Breast CancerRussian Federation
-
Shirish GadgeelMerck Sharp & Dohme LLCWithdrawnNon Small Cell Lung Cancer | PD-L1 Gene Mutation | Advanced Lung Non-Small Cell Carcinoma
-
Nir PeledNot yet recruitingNon Small Cell Lung Cancer | EGFR Gene Mutation | Immune Checkpoint InhibitorIsrael
-
CellSight Technologies, Inc.Not yet recruitingAdvanced Non Small Cell Lung Cancer
-
ImmunityBio, Inc.Active, not recruitingSolid Tumor | Metastatic Cancer | Locally Advanced Solid TumorUnited States
-
AstraZenecaActive, not recruitingNon-Small-Cell Lung CarcinomaFrance, Spain, Thailand, Belgium, Korea, Republic of, Netherlands, United States, Brazil, Japan, China, Malaysia, Taiwan, Australia, Denmark
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
UNC Lineberger Comprehensive Cancer CenterPfizerTerminatedMetastatic Urothelial Carcinoma (UC)United States
-
Sichuan UniversityRecruitingPleural Effusion, Malignant | Peritoneal Carcinoma MetastaticChina
-
Intergroupe Francophone de Cancerologie ThoraciqueActive, not recruitingNon-Small Cell Lung Cancer MetastaticFrance
-
Yonsei UniversityMerck KGaA, Darmstadt, GermanyActive, not recruitingPD-L1 Positive Mutation Tumor | EBV Positive Mutation Tumor | MSI-H Mutation Tumor | POLE/POLD1 Mutation TumorKorea, Republic of
-
Xinqiao Hospital of ChongqingCompleted
-
Guangzhou Institute of Respiratory DiseaseGeneCast Biotechnology Co., Ltd.Unknown
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Anaplastic Thyroid Cancer | Other Solid Tumors | Non-small Sell Lung Cancer (NSCLC)United States, Italy, Spain, Hungary, Taiwan, Germany, Netherlands, France, Norway, Poland, Thailand, Lebanon, Turkey, Canada
-
Merck Sharp & Dohme LLCCompleted
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingNSCLC | Lung Cancer | Non-small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage I | PD-L1 Gene Mutation | Non-small Cell Lung Cancer Stage IIIA | Non-small Cell Lung Cancer Stage IIUnited States
-
Naestved HospitalRecruitingNon-small Cell Lung Cancer | Malignant Pleural EffusionDenmark
-
Merck Sharp & Dohme LLCCompleted
-
Binhui Biopharmaceutical Co., Ltd.Recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Zhongnan HospitalRecruiting
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Assuntina Sacco, M.D.PfizerTerminated
-
Tongji UniversityRecruitingA Phase III Trial of Neoadjuvant Sintilimab and Chemotherapy for NSCLC Harboring No Driver MutationsNSCLC, Stage IIIA | EGF-R Negative Non-Small Cell Lung Cancer | ALK Negative NSCLCChina